Page last updated: 2024-08-22

2,2-bis(bromomethyl)-1,3-propanediol and Intestinal Diseases

2,2-bis(bromomethyl)-1,3-propanediol has been researched along with Intestinal Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Courtois, P; Malaisse, WJ; Scott, FW; Sener, A1
Courtois, P; Graham, S; Malaisse, WJ; Mowat, AM; Rozing, J; Scott, FW1

Other Studies

2 other study(ies) available for 2,2-bis(bromomethyl)-1,3-propanediol and Intestinal Diseases

ArticleYear
Disaccharidase activity in the intestinal tract of Wistar-Furth, diabetes-resistant and diabetes-prone BioBreeding rats.
    The British journal of nutrition, 2004, Volume: 91, Issue:2

    Topics: alpha-Glucosidases; Animals; beta-Fructofuranosidase; Diabetes Mellitus, Experimental; Diet; Disaccharidases; Female; Genetic Predisposition to Disease; Intestinal Diseases; Intestine, Small; Lactase; Male; Prediabetic State; Rats; Rats, Inbred BB; Sex Factors; Species Specificity

2004
Enteropathy precedes type 1 diabetes in the BB rat.
    Gut, 2004, Volume: 53, Issue:10

    Topics: Animals; beta-Fructofuranosidase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diet; Female; Intestinal Diseases; Intestinal Mucosa; Jejunum; Male; Prediabetic State; Rats; Rats, Inbred BB; Thymus Gland

2004